V. D. Ramanathan

1.3k total citations
50 papers, 1.0k citations indexed

About

V. D. Ramanathan is a scholar working on Infectious Diseases, Immunology and Epidemiology. According to data from OpenAlex, V. D. Ramanathan has authored 50 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Infectious Diseases, 16 papers in Immunology and 14 papers in Epidemiology. Recurrent topics in V. D. Ramanathan's work include Tuberculosis Research and Epidemiology (20 papers), Mycobacterium research and diagnosis (12 papers) and Leprosy Research and Treatment (8 papers). V. D. Ramanathan is often cited by papers focused on Tuberculosis Research and Epidemiology (20 papers), Mycobacterium research and diagnosis (12 papers) and Leprosy Research and Treatment (8 papers). V. D. Ramanathan collaborates with scholars based in India, United States and United Kingdom. V. D. Ramanathan's co-authors include Anil K. Tyagi, J.L. Turk, Harshavardhan Shakila, P R Narayanan, C N Paramasivan, B. Williamson, D. J. Johnston, Vivek Rao, Neeraj Dhar and Radhika Gupta and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Bacteriology.

In The Last Decade

V. D. Ramanathan

47 papers receiving 995 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
V. D. Ramanathan India	19	607	408	371	290	129	50	1.0k
B Rivoire United States	18	741 1.2×	702 1.7×	283 0.8×	240 0.8×	173 1.3×	28	1.3k
Sérgio Arruda Brazil	17	373 0.6×	467 1.1×	275 0.7×	270 0.9×	114 0.9×	74	1.1k
Angela M. Starks United States	15	591 1.0×	527 1.3×	321 0.9×	232 0.8×	217 1.7×	23	1.1k
Marion Sparrius Netherlands	14	330 0.5×	314 0.8×	342 0.9×	224 0.8×	209 1.6×	18	946
Marek Fol Poland	18	380 0.6×	305 0.7×	351 0.9×	277 1.0×	126 1.0×	41	1.0k
Leon Iri Kupferwasser United States	14	351 0.6×	312 0.8×	242 0.7×	69 0.2×	101 0.8×	16	817
Qian Gao China	22	417 0.7×	337 0.8×	532 1.4×	138 0.5×	128 1.0×	43	1.2k
Allison F. Gillaspy United States	21	607 1.0×	205 0.5×	894 2.4×	164 0.6×	100 0.8×	30	1.5k
L Beaman United States	14	497 0.8×	814 2.0×	165 0.4×	191 0.7×	120 0.9×	25	1.5k
Katrina Downing South Africa	14	599 1.0×	439 1.1×	391 1.1×	104 0.4×	101 0.8×	17	1.0k

Countries citing papers authored by V. D. Ramanathan

Since Specialization

Citations

This map shows the geographic impact of V. D. Ramanathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. D. Ramanathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. D. Ramanathan more than expected).

Fields of papers citing papers by V. D. Ramanathan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. D. Ramanathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. D. Ramanathan. The network helps show where V. D. Ramanathan may publish in the future.

Co-authorship network of co-authors of V. D. Ramanathan

This figure shows the co-authorship network connecting the top 25 collaborators of V. D. Ramanathan. A scholar is included among the top collaborators of V. D. Ramanathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. D. Ramanathan. V. D. Ramanathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ramanathan, V. D., et al.. (2025). Enhancing Cancer Screening and Early Diagnosis in India: Overcoming Challenges and Leveraging Emerging Technologies. Cureus. 17(2). e78808–e78808. 1 indexed citations

Savvidou, Maria G., V. D. Ramanathan, Thi Tho Bui, et al.. (2025). Multi-modal label-free imaging of cellular metabolism and oxidative stress in 3D brain tissue models. Communications Biology. 8(1). 1737–1737.

Emon, Bashar, et al.. (2025). Decoupling chemical and mechanical signaling in colorectal cancer cell migration. Scientific Reports. 15(1). 4952–4952. 1 indexed citations

Singh, Pragya, et al.. (2023). Extracellular Hsp90 Binds to and Aligns Collagen-1 to Enhance Breast Cancer Cell Invasiveness. Cancers. 15(21). 5237–5237. 4 indexed citations

Walsh, Ryan R., Steven P. Piccoli, Damon Love, et al.. (2023). Vodobatinib, a potent, orally bioavailable brain-penetrating inhibitor of c-Abl as a potential neuroprotective agent for treatment of Parkinson disease. Parkinsonism & Related Disorders. 113.

Cheedarla, Narayanaiah, Kamalakannan Vijayan, Chandrasekaran Padmapriyadarsini, et al.. (2017). Broad and potent cross clade neutralizing antibodies with multiple specificities in the plasma of HIV-1 subtype C infected individuals. Scientific Reports. 7(1). 46557–46557. 6 indexed citations

Brindha, P., et al.. (2015). What roles do herbs play in Kantacenturam : An iron oxide based herbo-mineral Siddha drug formulation?. Indian Journal of Traditional Knowledge. 14(3). 433–439. 1 indexed citations

Sundaramurthi, Jagadish Chandrabose, V. D. Ramanathan, & Luke Elizabeth Hanna. (2012). HLA-B*27:05-Specific Cytotoxic T Lymphocyte Epitopes in Indian HIV Type 1C. AIDS Research and Human Retroviruses. 29(1). 47–53. 3 indexed citations

Majumdar, Shyamasree De, Atul Vashist, Rajesh Kumar Gupta, et al.. (2012). Appropriate DevR (DosR)-Mediated Signaling Determines Transcriptional Response, Hypoxic Viability and Virulence of Mycobacterium tuberculosis. PLoS ONE. 7(4). e35847–e35847. 41 indexed citations

10.

Dey, Bappaditya, Ruchi Jain, Umesh Datta Gupta, et al.. (2011). A Booster Vaccine Expressing a Latency-Associated Antigen Augments BCG Induced Immunity and Confers Enhanced Protection against Tuberculosis. PLoS ONE. 6(8). e23360–e23360. 39 indexed citations

11.

Jain, Ruchi, Bappaditya Dey, Aparna Khera, et al.. (2011). Over-expression of superoxide dismutase obliterates the protective effect of BCG against tuberculosis by modulating innate and adaptive immune responses. Vaccine. 29(45). 8118–8125. 17 indexed citations

12.

Dey, Bappaditya, Ruchi Jain, Aparna Khera, et al.. (2011). Latency Antigen α-Crystallin Based Vaccination Imparts a Robust Protection against TB by Modulating the Dynamics of Pulmonary Cytokines. PLoS ONE. 6(4). e18773–e18773. 26 indexed citations

13.

Dey, Bappaditya, Ruchi Jain, Aparna Khera, et al.. (2009). Boosting with a DNA vaccine expressing ESAT-6 (DNAE6) obliterates the protection imparted by recombinant BCG (rBCGE6) against aerosol Mycobacterium tuberculosis infection in guinea pigs. Vaccine. 28(1). 63–70. 21 indexed citations

14.

Venkatesan, Prem, et al.. (2009). Defective Solubilization of Immune Complexes and Activation of the Complement System in Patients with Pulmonary Tuberculosis. Journal of Clinical Immunology. 29(5). 674–680. 6 indexed citations

15.

Karunakaran, K. P., et al.. (2008). Reduced erythrocyte CR1 levels in patients with pulmonary tuberculosis is an acquired phenomenon. Clinical Immunology. 128(1). 109–115. 12 indexed citations

16.

Begum, Rehana, et al.. (2006). Comprehensive findings on clinical, bacteriological, histopathological and therapeutic aspects of cutaneous tuberculosis. Tropical Medicine & International Health. 11(10). 1521–1528. 35 indexed citations

17.

Sharma, Deepak, Arpita Bose, Harshavardhan Shakila, et al.. (2006). Expression of mycobacterial cell division protein, FtsZ, and dormancy proteins, DevR and Acr, within lung granulomas throughout guinea pig infection. FEMS Immunology & Medical Microbiology. 48(3). 329–336. 31 indexed citations

18.

Malhotra, Vandana, Deepak Sharma, V. D. Ramanathan, et al.. (2004). Disruption of response regulator gene,devR, leads to attenuation in virulence ofMycobacterium tuberculosis. FEMS Microbiology Letters. 231(2). 237–245. 100 indexed citations

19.

Narayanan, Sujatha, et al.. (2000). Comparative evaluation of PCR using IS6110 and a new target in the detection of tuberculous lymphadenitis.. Current Science. 78(11). 1367–1370. 6 indexed citations

20.

Parkash, Om, V. D. Ramanathan, Dinesh Pratap Singh, & Utpal Sengupta. (1988). Effect of anti-mycobacterial antibodies on activation of the alternative pathway of the human complement system. FEMS Microbiology Letters. 55(3). 255–258. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact